We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

107 hedge funds and large institutions have $200M invested in Surgalign Holdings, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 28

1% less capital invested

Capital invested by funds: $201M → $200M (-$1.03M)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

2% less funds holding

Funds holding: 109107 (-2)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
107
Holders Change
-2
Holders Change %
-1.83%
% of All Funds
2.45%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
10
Increased
37
Reduced
28
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PCMI
1
Paradigm Capital Management Inc
New York
$27.9M +$1.26M +9,111 +5%
BlackRock
2
BlackRock
New York
$22.3M +$44.8K +325 +0.2%
Dimensional Fund Advisors
3
Dimensional Fund Advisors
Texas
$21M +$468K +3,394 +2%
KAM
4
Krensavage Asset Management
New York
$20.1M -$14.1K -102 -0.1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$13M +$1.72M +12,501 +15%
RSCM
6
Rock Springs Capital Management
Maryland
$8.78M
Renaissance Technologies
7
Renaissance Technologies
New York
$7.32M +$375K +2,723 +5%
RCM
8
Rutabaga Capital Management
Massachusetts
$6.33M +$143K +1,037 +2%
HC
9
Hillman Company
Pennsylvania
$4.86M
State Street
10
State Street
Massachusetts
$4.8M +$81.2K +589 +2%
RA
11
Royce & Associates
New York
$4.68M +$879K +6,378 +23%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$4.42M +$2.9K +21 +0.1%
Wellington Management Group
13
Wellington Management Group
Massachusetts
$4.15M +$2.37M +17,223 +128%
FP
14
Foundry Partners
Minnesota
$4.11M -$606K -4,398 -13%
KIA
15
Kopp Investment Advisors
Minnesota
$4.04M +$134K +973 +3%
BCM
16
Bridgeway Capital Management
Texas
$3.08M +$365K +2,651 +13%
Northern Trust
17
Northern Trust
Illinois
$3.03M +$50.7K +368 +2%
AL
18
AJO LP
Pennsylvania
$2.73M -$241K -1,748 -8%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$2.55M +$132K +956 +5%
Victory Capital Management
20
Victory Capital Management
Texas
$1.54M +$391K +2,835 +33%
WCM
21
Wedge Capital Management
North Carolina
$1.46M
Russell Investments Group
22
Russell Investments Group
United Kingdom
$1.38M +$1.06M +7,671 +299%
Deutsche Bank
23
Deutsche Bank
Germany
$1.34M +$42K +305 +3%
Boston Partners
24
Boston Partners
Massachusetts
$1.31M +$1.34M +9,690 New
AA
25
Ancora Advisors
Ohio
$1.27M +$1.65K +12 +0.1%

SRGA Hedge Fund Activity: Q3 2018 in Review

107 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q3 2018, worth a combined $200M — down 0.51% from $201M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of SRGA and 10 opened new positions — a net loss of 1 holder — while 28 trimmed existing stakes and 37 added.

The largest buyer was Wellington Management Group, adding an estimated $2.37M. The largest seller was Kennedy Capital Management, cutting an estimated $3.06M.

  • 107 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q3 2018, down from 109 in Q2 2018.
  • Funds reported $200M of Surgalign Holdings, Inc. Common Stock stock for Q3 2018, down 0.51% quarter-over-quarter.
  • 10 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q3 2018 and 11 closed out, a net change of -1 holder.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q3 2018 was Wellington Management Group, an estimated $2.37M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q3 2018 was Kennedy Capital Management, an estimated $3.06M sold.

Based on aggregated 13F filings for Q3 2018.